Cipher Pharmaceuticals Inc.

TSX:CPH.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$13.05 +0.94%

+$0.15 today

Market cap
$331.67M
Beta
0.48
P/E (TTM)
9.3
EPS (TTM)
$1.22
52W Low $11.98High $20.56

Volume 0.04M

Average 0.03M

CPH.TO Deferred Income Tax

The difference between tax expense recognized and tax actually paid in cash during the period.

Cipher Pharmaceuticals Inc.TSX: CPH.TO

Deferred Income Tax · Q1 FY2026 · quarter ended Mar 2026

Deferred income tax growth accelerates

Q1 FY2026 deferred income tax of $1.19M (cash outflow) rose 62.0% year over year, ahead of the +43.2% change in trailing-twelve-month deferred income tax. Sequentially, it fell 86.3% from the prior quarter. Over 3 fiscal years it compounded at -10.2% a year.

Context

  • Deferred income tax amounted to 20.2% of revenue in FY2025, down 5.7 pp from a year earlier.
  • Deferred income tax grew in size in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +62.0% holds above the trailing-twelve-month pace of +43.2%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$1.19M-86.3% QoQ
Last fiscal yearDec 2025
-$10.36M+19.8% YoY
LTMMar 2026
-$10.64M+43.2% YoY
Deferred Income Tax past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+62.0%——
1 year+19.8%——
3-year CAGR-10.2%——
5-year CAGR——
10-year CAGR——

Deferred Income Tax history

USD · from the cash flow

Latest · FY2025
(10.36M) USD
Year-over-year change
-19.8%

Deferred Income Tax vs competitors

How CPH.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so deferred income tax is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +43.2% is the 3rd highest of 6, against a peer median of -98.5%.
  • Deferred income tax amounts to 20.9% of revenue for CPH.TO, versus a peer median of 0.0%.
CPH.TO Competitors
Deferred Income Tax for CPH.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026CA$13.66M CAD-45646.7%—5.0%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$10.64M USD+43.2%-10.2%20.9%
TSND.TOTerrAscend Corp.LTM Mar 2026$1.1M USD-140.2%-77.4%0.4%
GUD.TOKnight Therapeutics Inc.LTM Mar 2026CA$138K CAD+106.6%-39.4%0.0%
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$107.47K CAD-98.5%—0.0%
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$55K CAD+101.7%—0.0%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$0 USD——0.0%
EDT.TOSpectral Medical Inc.LTM Mar 2026CA$0 CAD——0.0%
Peer median (excluding CPH.TO) —-98.5%-58.4%0.0%

Competitors are the stored peer set for CPH.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income7.76M26.64M20.38M11.55M27.33M
Depreciation & Amortization701K989K1.23M4.02M7.23M
Deferred Income Tax(114K)(14.31M)(2.74M)(8.64M)(10.36M)
Stock-Based Compensation139K403K1.19M1.07M1.74M
Change in Working Capital4.68M(3.03M)(3.28M)8.95M5.32M
Accounts Receivables2.56M(144K)1.71M(8.77M)2.7M
Inventory(758K)(502K)(830K)3.6M(2.44M)
Accounts Payables(1.23M)(1.45M)532K1.28M527.07K
Other Working Capital4.11M(940K)(4.69M)12.85M4.53M
Other Non-Cash Items652K(109K)(788K)2.6M(1.01M)
Operating Cash Flow13.81M10.58M16M19.55M30.25M
Capital Expenditures0(81K)(144K)(44K)(28.49K)
Acquisitions (Net)0000132.28K
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities00(123K)(80M)0
Investing Cash Flow0(81K)(144K)(80.04M)(72.24K)
Debt Repayment(828K)(56K)(111K)39.79M(35.61M)
Common Stock Issued0000218.76K
Common Stock Repurchased(1.72M)(1.99M)(5.56M)(176K)(5.48M)
Dividends Paid00000
Other Financing Activities75K132K426K(317K)(311.36K)
Financing Cash Flow(2.47M)(1.91M)(5.24M)39.3M(41.18M)
Effect of Forex Changes62K(292K)378K(786K)(194.92K)
Net Change in Cash11.41M8.29M10.99M(21.99M)(11.2M)
Free Cash Flow13.81M10.49M15.98M19.5M30.22M

Cipher Pharmaceuticals Inc.

TSX:CPH.TO

Intrinsic Alpha fair value

Locked

Current Price

$13.05

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.